do glp 1 agonists cause pancreatic cancer The Use of Glucagon-like Peptide-1 Receptor in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Cancer: A U.S.-Based Cohort Study GLP-1 medications linked to major
Description
Literature Search and Inclusion Criteria This narrative review was based on a targeted search of PubMed, Scopus, and Web of Science, as well as official regulatory agencies, manufacturers of GLP-1RAs, and specialized entities providing economic estimates, to identify relevant publications on GLP-1RAs and obesity
We operate under GMP-compliant and ISO-certified standards, ensuring consistent quality, regulatory alignment, and customer confidence
Giugliano D, Scappaticcio L, Longo M, Caruso P, Maiorino MI, Bellastella G, et al
[DOI] [PubMed] [Google Scholar] 36.Holst J.J
